=== Page 98 ===
IBA Annual Report 2023 
95. IBA 
to a streghtened backlog conversion in H2. We 
also see a good order intake for Other 
Accelerators, as well as continued growth for 
Dosimetry. For the year ended on December 31, 2023, the 
Group 
gross 
margin 
(31.4%) 
worsened 
compared to 2022 (35.1%) following inflation 
and lower overhead absorption. The previous 
year performance was also positively impacted 
by indemnities related to the Rutherfords 
bankruptcy.